FINNENCE▪
00:00:00 UTCSYS ONLINE
FINNENCE ▪ THE WIRE FILE

THE WIRE · № 71114

News■ Unclear/unknown

LevEllis™ Expands Executive Leadership to Scale PROVOQUE™ and Advance Its Regenerative Platform

EXHIBIT · mmx.prnewswire.com
KINDNews
DIRECTION■ Unclear/unknown
SOURCES1
ENTITIES1
STORY SIZESTANDALONE
FIRST SEEN2026-10-08 13:15 UTC
LAST UPDATE2026-10-08 13:15 UTC
STATEactive

01 THE MACHINE READ

WHY IT MATTERS.

Biotech leadership hires signal commercial buildout; no financial or clinical data provided.

Biotech scales commercial team pre-launch
CATALYST TO WATCH

Product launch or trial data

MAIN RISK

Commercial push without proven demand

FULL DISPATCH

Renee Romero Pedroza appointed Chief Marketing Officer and Wendy Patrick named Vice President of Sales as LevEllis builds its commercial organization for the next phase of growth ASHEVILLE, N.C., Oct. 8, 2026/PRNewswire/ -- LevEllis, Inc., the biotechnology company behind PROVOQUE™ by...

02 THE STORY SO FAR

THE RECORD, IN ORDER.

STANDALONE ITEM — NOT YET FOLDED INTO A DEVELOPING STORY.

03 WHO'S INVOLVED

ENTITIES ON FILE.

AFFECTEDHealthcare

04 RECEIPTS

THE SOURCE RECORD.

1 SOURCES CONFIRMED
№ 01prnewswireprnewswire.com · PRIMARY2026-10-08 13:15 UTCOPEN RECEIPT →

05 PROPAGATION

WHAT THIS TOUCHES.

→CORRELATIONshares Healthcare
Illumina releases SpliceAI2 to help advance rare disease research
2026-10-08 13:15 UTC
→CORRELATIONshares Healthcare
Iambic aims for $135M IPO to push cancer drugs through clinic
2026-10-08 12:45 UTC
→CORRELATIONshares Healthcare
Money Matters: Oil Prices Increase & Prescription Costs Rise
2026-10-08 13:27 UTC
→CORRELATIONshares Healthcare
AI drug discovery startup Iambic seeks $150M in IPO
2026-10-08 13:41 UTC

KEEP READING THE MACHINE

OPEN THE MACHINE →THE PREDICTION LEDGER →

Summaries are generated and may contain errors — every claim links its sources.